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Abstract
Background: Glioblastoma multiforme is the most common and most aggressive malign brain tumor. The 5-year
survival rate after tumor resection and adjuvant chemoradiation is only 10 %, with almost all recurrences occurring
in the initially treated site. Attempts to improve local control using a higher radiation dose were not successful so
that alternative additive treatments are urgently needed. Given the strong rationale for hyperthermia as part of a
multimodal treatment for patients with glioblastoma, non-invasive radio frequency (RF) hyperthermia might
significantly improve treatment results.
Methods: A non-invasive applicator was constructed utilizing the magnetic resonance (MR) spin excitation
frequency for controlled RF hyperthermia and MR imaging in an integrated system, which we refer to as thermal
MR. Applicator designs at RF frequencies 300 MHz, 500 MHz and 1GHz were investigated and examined for
absolute applicable thermal dose and temperature hotspot size. Electromagnetic field (EMF) and temperature
simulations were performed in human voxel models. RF heating experiments were conducted at 300 MHz and
500 MHz to characterize the applicator performance and validate the simulations.
Results: The feasibility of thermal MR was demonstrated at 7.0 T. The temperature could be increased by ~11 °C in
3 min in the center of a head sized phantom. Modification of the RF phases allowed steering of a temperature
hotspot to a deliberately selected location. RF heating was monitored using the integrated system for MR
thermometry and high spatial resolution MRI. EMF and thermal simulations demonstrated that local RF
hyperthermia using the integrated system is feasible to reach a maximum temperature in the center of the human
brain of 46.8 °C after 3 min of RF heating while surface temperatures stayed below 41 °C. Using higher RF
frequencies reduces the size of the temperature hotspot significantly.
Conclusion: The opportunities and capabilities of thermal magnetic resonance for RF hyperthermia interventions of
intracranial lesions are intriguing. Employing such systems as an alternative additive treatment for glioblastoma
multiforme might be able to improve local control by “fighting fire with fire”. Interventions are not limited to the
human brain and might include temperature driven targeted drug and MR contrast agent delivery and help to
understand temperature dependent bio- and physiological processes in-vivo.
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Background
Glioblastoma multiforme is the most common and most
aggressive malign brain tumor. Despite demarcation in
computed tomography (CT) or magnetic resonance im-
aging (MRI) glioblastoma multiforme presents no clear
microscopic barriers towards the unaffected brain [1].
This pathology makes a complete surgical resection chal-
lenging if not elusive. Recurrences are typically located in
the former tumor region and therefore intensification of
local treatment is required. Yet, the first therapeutic
attempt is to resect the tumor as completely as possible.
Radiation therapy adjuvant to resection improves overall
survival versus resection alone [2]. Since 2004 the stand-
ard of care consists of combined adjuvant chemoradiation
using temozolomide [3]. Arguably, the 5-year survival rate
after tumor resection and adjuvant chemoradiation is only
10 %, with almost all recurrences occurring in the initially
treated site [3, 4]. Attempts to improve local control using
a higher radiation dose were not successful [5] so that al-
ternative additive treatments are urgently needed. Intersti-
tial hyperthermia in addition to external beam radiation
therapy and brachytherapy of the brain has been demon-
strated to improve survival in a randomized trial [6]. This
type of treatment is not applicable to all tumor locations
within the brain, and did not become accepted in clinical
practice due to its invasive nature.
Another thermal therapy approach is nanotherapy,
where a dispersion of iron-oxide (magnetite) nanoparti-
cles is injected into the tumor which is subsequently
heated in an alternating magnetic field [7]. This therapy
was evaluated in combination with a reduced dose of ex-
ternal beam radiation (median dose 30 Gy) in a single-
arm study with patients predominantly with recurrent
glioblastoma [8]. The treatment was well received and
appeared effective. Notwithstanding this clinical success
nanotherapy assumes a sufficient coverage of the tumor
region by the nanoparticles, which can be difficult under
clinical conditions. In addition, the efficiency of the cur-
rently available nanoparticles and the frequency of the
magnetic field constitute constraints which require fur-
ther technological improvements. In this light, nanother-
apy for glioblastoma is presently considered not to be
ready for routine clinical use. Given the strong rationale
for the successful use of hyperthermia as part of a multi-
modal treatment for patients with glioblastoma [9], non-
invasive radiofrequency (RF) hyperthermia might signifi-
cantly improve treatment results, in addition to standard
chemoradiation. To evaluate treatment efficiency non-
invasive three dimensional thermal dose evaluation is
necessary [10]. MRI is of proven diagnostic value with
an ever growing number of applications that support
thermal therapies [11, 12]. In current clinical regional
RF hyperthermia practice MR thermometry (MRTh) is
used for spatiotemporal monitoring of temperature and
treatment efficiency [13–15]. While the RF transmission
used for MRI is commonly performed at a frequency of
64 MHz (B0 = 1.5 T), RF transmission induced heating
interventions in this hybrid systems are achieved with
RF antennas usually driven at ~100 MHz [16]. The RF
wavelength at 100 MHz is approximately 33 cm in brain
tissue, which is not suitable to focus the electromagnetic
(EM) energy selectively enough to brain tumors with a
tumor size of few centimeters. Higher RF frequencies
(f > 100 MHz) are suitable to be applied in the head
and neck region to perform localized RF hyperthermia
[17–20]. Unfortunately, established systems still lack
the ability of non-invasive 3D temperature measure-
ment to monitor and control the thermal dose ap-
plied in the treated region and in healthy tissue.
Realizing this challenge it was demonstrated, that ultra-
high magnetic fields (UHF, B0 ≥ 7.0 T) render an inte-
grated applicator feasible; including a configuration
suitable for MRI, MRTh and controlled targeted RF heat-
ing utilizing a single transmission frequency of 300 MHz
[20]. The applicator employs the proton MR frequency for
targeted RF heating and can be used together with com-
mercially available MR systems and multi-channel RF
transmission configurations for imaging diagnostics and
for RF hyperthermia applications [20]. Such integrated sys-
tem will be referred to as thermal MR. The early results
indicated that this approach is conceptually appealing for
a therapeutic application to intracranial lesions since pre-
treatment diagnosis and planning, peri-treatment thermal
dose control and adaptation and post-treatment evaluation
of the treatment efficiency can be performed with a single
device. Recognizing this opportunity this work presents
physics considerations together with preclinical results de-
rived from a thermal MR applicator driven at 300 MHz.
For comparison, applicator designs are proposed which
are capable of utilizing even higher RF frequencies (up to
1 GHz). This approach holds the promise to benefit an ef-
fective reduction of the achievable thermal hotspot size.
To meet this goal electromagnetic field (EMF) simulations
are performed in a human voxel model deduced from a
healthy volunteer. Physics considerations and RF antenna
designs are presented for 300 MHz, 500 MHz and 1 GHz
which correspond to 7.0 T, 11.7 T or 23.5 T with an effect-
ive wavelength of approximately 13.5 cm, 8.6 cm and
4.5 cm in brain tissue. These efforts are complemented by
RF heating experiments conducted at 500 MHz. The pre-
liminary results suggest that such high frequency systems
could be used in two configurations. (i) an integrated
thermal MR application [20] in conjunction with a 7.0 T,
11.7 T or 23.5 T UHF MR system or (ii) a hybrid configur-
ation [21, 22] using an external RF power amplifier for RF
heating together with a conventional MR systems at 1.5 T
or 3.0 T. The merits and limitations of physics, technology
and clinical applicability of thermal MR are discussed in
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All imaging studies were performed after due approval
by the local ethical committee (registration number DE/
CA73/5550/09, Landesamt für Arbeitsschutz, Gesund-
heitsschutz und technische Sicherheit, Berlin, Germany).
Informed written consent was obtained from each vol-
unteer prior to the study. For the in-vivo proof-of-
concept study at 7.0 T, 1 healthy subject without any
known history of neuro- or cardiovascular diseases was
included.
Thermal MR applicator and RF antenna design
A thermal MR applicator was constructed to be oper-
ated with a 300 MHz (B0 = 7.0 T) MR scanner (Siemens
Healthcare, Erlangen, Germany). The applicator consists
of eight antenna building blocks placed in a symmetrical
arrangement around a cylindrical phantom (Fig. 1a). The
building blocks are driven by an 8-channel multi-
transmit system of the MR scanner (TX-Array, Siemens
Healthcare, Erlangen, Germany) utilizing an 8 x 1 kW
array of pulsed RF power amplifiers (Stolberg HF Tech-
nik AG, Stolberg-Vicht, Germany) (Fig. 1b) [20]. The
pulsed power amplifier allows to be driven at Pmax with
10 % duty cycle and a pulse length of 5 ms resulting in
an average power of 800 W. For a short period the duty
cycle can be increased to >20 % doubling the available
average power. Each antenna building block consists of a
λ/2 electric dipole antenna in a bow tie shape and a high
permittivity dielectric (Deuteriumoxide (D2O), isotopic
purity 99.9 atom % D, εr = 80) [20]. The use of D2O as a
substrate facilitates 1H MRI free of signal contributions
from deuterium since the gyromagnetic ratio of 2H deviates
from hydrogen. This prevents artefacts due to limitations in
the dynamic imaging range caused by strong B1
+ field con-
tributions in the vicinity of the electric dipole antenna. The
high permittivity of the substrate allows shortening of the
electric dipole length of the antenna since the wavelength
in this medium is reduced by approximately √εr. This
Fig. 1 a-b Experimental setup of an 8-channel thermal MR applicator comprising an array of bow tie dipole antennas that support MR imaging, MRTh
and targeted RF heating. c-d Experimental setup of a hybrid system using an external RF signal generator and RF amplifier at 500 MHz for RF heating,
while MRI and MRTh is being performed at 7.0 T with a RF coil operated at 300 MHz. The power amplifier was calibrated to provide an output of 70 W
at the end of the feeding cable. A power meter was used to monitor forward and reflected power during the RF heating experiments
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enables antenna positioning around the human head with
an application in the human brain. The Poynting vector of
such arrangement is directed towards the target region for
RF heating and MRI, with the E-fields being parallel to the
electric dipole which are aligned with the direction of the
static magnetic field B0 (z-direction). In the radio frequency
range induced temperature elevations are predominantly
caused by E-fields [23], which are the dominant factor of
power absorption in tissue as expressed by the specific
absorption rate (SAR):
SAR ¼










with σ(f) the frequency dependent electrical conductivity








2 the amplitude of
the electric field vector. The H-fields perpendicular to B0
(x-y-direction) form the spin excitation field B1
+ to be
exploited for MRI and MRTh.
Even though certain ceramics (e.g., BaTiO3) can be
used as a substrate with lower loss tangents than D2O, a
liquid dielectric is preferred as a substrate in our imple-
mentation. An RF hyperthermia application with high
RF power might lead to temperature elevations in the
substrate caused by RF losses or thermal conductivity.
The temperature dependence of the electromagnetic
properties and hence the impedance of the substrate
exhibits the risk to increase power reflections due to
impedance mismatch during the cause of a treatment. A
liquid dielectric offers the flexibility and benefit to be
used in a temperature control circuit to stabilize the
substrate temperature.
Electromagnetic field simulations
To investigate the EMF and SAR distribution, finite inte-
gration technique simulations were performed with CST
Microwave Studio 2012 (CST, Darmstadt, Germany).
Employing higher RF frequencies (f > 300 MHz) allows to
reduce the size of the power absorption hotspot along x-,
y- and z-dimension. In the x-y-plane (Fig. 1b) the hotspot
size is determined by the RF wavelength in a lossy dielec-
tric or brain tissue. The hotspot dimensions along the
z-direction can be reduced by decreasing the size of the
dielectric at higher RF frequencies, which allows for
smaller transmit elements along that axis or by the use of
multiple antenna rings [24–26]. To quantify these effects,
SAR distributions produced by two 8-channel setups con-
sisting of RF antenna building blocks with a fixed sub-
strate size of (150 × 70 × 40) mm3 were examined at
300 MHz and 500 MHz (Fig. 2a, b, d, e). These configura-
tions were benchmarked against a smaller substrate size of
(70 × 40 × 20) mm3 at 500 MHz (Fig. 2c, f ). For this pur-
pose the antennas were placed around a cylindrical phan-
tom (diameter = 180 mm, length = 250 mm) with tissue
properties (εr = 75, σ = 0.72 S/m). The effective dimensions
of deep lying hotspots were analysed using iso-contour
calculations of the SAR distribution. For this purpose iso-
SAR 25 %, iso-SAR 50 %, iso-SAR 75 % and an iso-SAR
90 % thresholds were derived for x-, y- and z-
dimension based on the maximum point SAR value.
SAR1g (1 g average, IEC 62407–1) was calculated for
human voxel “Ella” from the virtual family [27].
Hybrid RF heating at 500 MHz
To validate the results derived from the numerical simu-
lations and to demonstrate that the RF frequency used
Fig. 2 a-f Constructed bow tie building blocks used for RF heating in an integrated or hybrid system (a-c) sagittal and (d-f) coronal view. (a,d)
300 MHz setup with the dimensions (150 × 70 × 40) mm3 and D20 as a substrate. (b,e) 500 MHz setup with the dimensions (150 × 70 × 40) mm
3
and (c,f) with the dimensions (70 × 40 × 20) mm3, while deionized water has been used as a substrate
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for targeted RF heating may differ from the magnetic
resonance frequency used for MRTh, RF heating experi-
ments were performed at 500 MHz while MRI and
MRTh was conducted at 7.0 T (300 MHz). The RF heating
setup of the hybrid approach is shown in Fig. 1b and con-
sists of a signal generator (Rhode & Schwarz, Munich,
Germany), a class A linear RF power amplifier (RFPA)
module (LZY-1, Mini-Circuits, New York, USA) capable
to provide a continuous wave output power of ~ Pout =
140 W at f = 100–500 MHz and two power reflection me-
ters (Rhode & Schwarz, Munich, Germany). One power
meter was used to monitor transmitted and reflected
power during the experiments, while the other power
meter was used together with a 30 dB damping and a 50Ω
termination to calibrate the RF losses introduced by the
RF cable connecting the RFPA and the antenna. A single
bow tie dipole antenna (150 × 70 × 40) mm3 was applied
to induce RF heating in a custom made cylindrical phan-
tom (diameter = 180 mm, length = 250 mm) (Fig. 2b, e).
The phantom has an outer shell of polymethylmethacry-
late filled with a mixture of deionized water, copper sulfate
(Cu(II)-SO4, 0.74 g/l) and sodium chloride (NaCl, 3.33 g/l)
to resemble conductivity and permittivity of brain tissue.
Agarose (C12H18O9, 20 g/l) was used as a gelling agent to
suppress thermal convection. The resulting electromag-
netic properties (εr = 72, σ = 0.75 S/m) were measured
based on impedance measurements with a network
analyzer (Agilent 4296B, Santa Clara, CA, USA). For RF
heating an input power of 70 W was calibrated at the an-
tennas feeding point. An RF heating duration of 12 min
was used. To support 1H MRTh, the setup was placed
inside a birdcage volume RF coil (Siemens Healthcare,
Erlangen, Germany, f = 300 MHz, inner diameter = 34 cm).
As a high permittivity substrate for the RF heating anten-
nas at 500 MHz deionized water was used instead of D20.
In this particular arrangement the B1
+ amplitude in the sub-
strate and the phantom exhibits signal variations that fall
well within the dynamic imaging range while the electro-
magnetic properties (RF losses and permittivity) of both
D20 and H20 are comparable. MRTh was conducted
using the proton resonance frequency shift (PRFS)
method with a dual gradient echo technique (TE1 =
22.6 ms, TE2 = 6.34 ms) and a spatial resolution of
(1.9 × 1.9 × 5) mm3 [28, 29]. B0 drift (0.02 ppm/h) was com-
pensated with a vegetable oil sample as a reference [30].
Thermal simulations
For a more realistic scenario, EMF simulations were
performed with the voxel model “Ella” from the virtual
family [27] at 300 MHz, 500 MHz and 1 GHz. All electro-
magnetic properties of the voxel model are based on [31].
The values for brain grey and white matter and blood are
surveyed in Table 1. To demonstrate an advantage of even
higher RF frequencies for a more localized RF heating, a
20-channel antenna array consisting of electrical dipole
antennas (length = 142 mm) driven at 1 GHz was imple-
mented and compared with the 300 MHz and 500 MHz
setups. SAR distributions were calculated for an in-phase
(0° phase shift between channels) phase setting. The
power loss distribution was used as an input for the ther-
mal simulations. Thermal simulations were conducted
using CST MPhysics (CST, Darmstadt, Germany) solving




¼ ∇k∇T þ ρt SARð Þ
þ A−ρbcbρtFt T−Tbð Þ ð2Þ
with the specific heat of tissue ct in [J/(kg ⋅ °C)], the tis-
sue density ρt in [kg/m
3], tissue temperature T in [°C],
thermal conductivity of tissue k in [W/(m ⋅ °C)], the basal
metabolic heat generation rate of tissue A in [W/kg], the
blood density ρb = 1060kg/m
3, the specific heat of blood
cb = 3900J/(kg ⋅ °C), the tissue heat transfer rate Ft in
[ml/(min ⋅ kg)] and the blood temperature Tb = 37°C.
The heat capacity and thermal conductivity of the phan-
tom material was cphantom = 3546J/(kg ⋅ °C) and kphantom =
0.53W/(m ⋅ °C) respectively. Please note that the basal
metabolic heat generation rate and the term related to
blood perfusion in Eq.2 are not considered for the thermal
simulations in the phantom. The head of the human voxel
model “Ella” from the virtual family was used, with a voxel
size of (2 × 2 × 2) mm3 and thermally adjusted parameters
based on [31]. All thermal parameters can be found in
[31], thermal values for grey and white matter of the brain
and blood are summarized in Table 1. RF heating in the
Table 1 Electromagnetic and thermal properties of brain tissue













300 MHz 500 MHz 1 GHz 300 MHz 500 MHz 1 GHz
White matter 43.8 41 38.6 0.41 0.47 0.62 1041 3583 0.48 212 4.32
Grey matter 60 55.8 52.3 0.69 0.78 0.99 1045 3696 0.55 764 15.54
Blood 65.7 63.3 61.1 1.32 1.38 1.58 1060 3900 0.52 10000 0
Electromagnetic and thermal properties for 300 MHz, 500 MHz and 1 GHz of brain grey matter, brain white matter and blood used in the electromagnetic simulations
with the human voxel model “Ella” [28]. All other material parameters used in the electromagnetic field simulations (e.g., skin or fat) can be found in [29]
Winter et al. Radiation Oncology  (2015) 10:201 Page 5 of 12
voxel model was simulated for a duration of 3 min with a
constant input power of 400 W per applicator. This
approach resulted in an effective input power of 50 W per
antenna at 300 MHz and 500 MHz and 20 W per antenna
at 1 GHz. RF antenna and RF component losses were not
taken into account. A water bolus of a fixed temperature
of 20 °C was used to cool the surface. The effective dimen-
sions of deep lying temperature hotspots were analysed
using iso-contour calculations of the temperature differ-
ence with regards to baseline temperature (37 °C). For this
purpose iso-Temperature 90 %, iso-Temperature 75 %,
iso-Temperature 50 % and iso-Temperature 25 %
thresholds were derived based on the maximum over-
all temperature increase.
Results and discussion
Thermal MR applicator and antenna design
The thermal MR 8-channel applicator supports high
spatial resolution MRI at 7.0 T (Fig. 3a-b), MRTh
(Fig. 3c-d) and targeted RF heating (Fig. 3c-d) in a cylin-
drical phantom mimicking brain tissue properties and
the size of a human head [20]. The RF power of the MR
system is sufficient to increase the temperature by ap-
proximately 11 °C in 3 min (Fig. 3c) [20]. The multi-
channel transmit system of the MR scanner can be used
to deliberately alter and steer the location of the hotspot
(Fig. 3d) [20]. Thermal simulations in a human voxel
model demonstrated that these phase settings can be
reproduced to generate a hotspot in the center (Fig. 3e)
Fig. 3 a-b MR images of the human brain acquired with the thermal MR 8-channel applicator at 7.0 T. A gradient echo technique is shown with
a spatial resolution of (0.5 × 0.5 × 2.0) mm3. c MRTh maps of an RF heating experiment on a cylindrical phantom using the applicator to focus
SAR in the center of the phantom and to acquire MR images to be used for the MRTh method. The pulsed power RF amplifier of the MR system
was used at 300 MHz (1H proton excitation frequency at 7.0 T) to induce a temperature difference of ~11 °C in the center of the phantom after
3 min of RF heating. d Demonstration of 2D hotspot steering feasibility of the given setup with RF phase modulation between the channels [20].
A temperature of >7 °C in the vicinity of the phantom could be reached for an RF heating duration of 2 min. e-f Thermal simulations in human
voxel model “Ella” [27] in order to demonstrate the capabilities of the applicator to generate a hotspot in (e) the center of the brain and (f) the
periphery applying the same phase setting as in (d)
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and in the vicinity (Fig. 3f ) of the human brain. The use
of higher RF frequencies for targeted RF heating was
found to decrease the hotspot size (Fig. 4). At 500 MHz
(Fig. 4c-f ), the dimensions of the SAR hotspot are sig-
nificantly reduced (Table 2) from an iso-SAR 90 % value
of (18 × 18 × 41) mm3 at 300 MHz to an iso-SAR 90 %
value of (10 × 10 × 40) mm3 for the same antenna build-
ing block size (Fig. 4a-d, Table 2). Iso-SAR 75 % was
(29 × 29 × 70) mm3 for 300 MHz and (17 × 17 × 73) mm3
for the same antenna building block size at 500 MHz
(Table 2). Since the RF wavelength is shortened at
500 MHz, the dipole antenna and size of the dielectric
can be reduced to enable smaller building block ele-
ments with a size of (70 × 40 × 20) mm3 (Fig. 4e-f ) as
compared to the larger elements (size = (150 × 70 × 40)
mm3) used at 300 MHz and 500 MHz (Fig. 4a-d). The
volume reduction of the building block by a factor of >7,
in particular along the main axis of the bow tie antenna
aligned with the z-direction, resulted in a smaller hotspot
size (−32 %) along that axis (Table 2). An iso-SAR 90 %
of (10 × 10 × 28) mm3 and an iso-SAR 75 % of (17 ×
17 × 48) mm3 were found for the 8-channel setup
(Fig. 4e-f, Table 2). The constructed bow tie building
blocks are shown in Fig. 2 including a 300 MHz an-
tenna (Fig. 2a, d), the 500 MHz counterpart (Fig. 2b, e)
and the smaller 500 MHz version (Fig. 2c, f ). The
smaller RF antenna building block has the handicap of
increased surface SAR values and a reduced absolute
SAR value of 116 W/kg at the center of the phantom as
compared to 176 W/kg at 500 MHz and 216 W/kg at
300 MHz for an input power of Pin = 400 W (Table 2).
However its smaller size allows for more elements to be
placed around the object which holds the promise to
potentially reduce surface SAR hotspots, to increase the
degree of freedom for transmission field shimming and
hotspot steering and to boost the number of receive
elements for higher signal-to-noise ratio (SNR) and ac-
celerated acquisitions in an MRI application [32].
Fig. 4 Comparison of the simulated SAR distributions for three 8-channel bow tie dipole antenna configurations and a total input power of 400 W
(50 W per antenna). (a-b) Bow tie building block at 300 MHz with dimensions (150 × 70 × 40) mm3, (c-d) bow tie building block at 500 MHz
with dimensions (150 × 70 × 40) mm3 and (e-f) a smaller sized (70 × 40 × 20) mm3 bow tie building block at 500 MHz. The local SAR hotspot size in
the center of the phantom was significantly reduced at 500 MHz. A reduction in the length of the dielectric at 500 MHz (e-f) yielded smaller hotspot
dimensions along the main axis of the bow tie antenna. (g) Comparison of the normalized point SAR derived from electromagnetic field simulations
along a line from the surface to the center of a cylindrical phantom for three 8-channel arrangements of the building blocks. For all configurations the
antenna building blocks are driven in phase (Ch1-8 = 0°) to generate a hotspot in the center of the phantom
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Hybrid RF heating at 500 MHz
The results of the RF heating experiments at 500 MHz
and MRI at 300 MHz are summarized in Fig. 5 together
with the thermal simulations derived from a virtual
setup. The external RFPA is not MR compatible and was
positioned in the operator room, which made the use of
long RF cables necessary to connect the RFPA with the
RF antenna. This connection introduced cables losses of
−2.7 dB at 500 MHz, resulting in a required power output
of 130 W at the RFPA to reach an input power of 70 W at
the antenna. Additional RF losses, which increase with RF
frequency, resulted from the deionized water used as a
dielectric with a measured electrical conductivity at
500 MHz of 0.14 S/m. However the RF power achieved
was sufficient to generate a maximum temperature in-
crease of ΔT > 15 °C after 12 min heating in simulations
and measurements (Fig. 5). MRTh was performed without
any imaging artefacts caused by the RF antenna building
block. The measured temperature profile shows good cor-
relation with the simulated data (Fig. 5). Benchmarking of
thermal simulations against measurements yielded a
temperature difference <2 °C for surface regions, which
might be attributed to imperfect thermal modelling in
these locations. In comparison, a temperature difference
of less than 1 °C was found at depth (>40 mm) (Fig. 5).
Thermal simulations in human voxel models
The thermal simulation results obtained for an 8-
channel applicator at 300 MHz, an 8-channel applicator
at 500 MHz and a 20-channel applicator at 1 GHz posi-
tioned around the head of the human voxel model “Ella”
are presented in Fig. 6. The hotspot was focused to
the center of the brain to demonstrate, that targeted
RF heating is not restricted to surface regions and
can be performed for deep seated intracranial lesions.
For an input power of 400 W and an RF heating dur-
ation of only 3 min, all setups were found capable to
deliver sufficient energy absorption in the center of
the brain (maxSAR1g = 311 W/kg for 300 MHz, max-
SAR1g = 240 W/kg for 500 MHz and maxSAR1g =307 W/
kg for 1 GHz) in order to reach temperatures above 44 °C.
The thermal simulations showed that after 3 min the
300 MHz setup reached a maximum temperature of
Tmax = 46.8 °C in the center of the human brain
resulting in a temperature difference of ΔT = 9.8 °C
versus baseline. This value correlates well with the
temperature difference of ΔT = 10.7 °C measured pre-
viously in phantom experiments using the same RF
heating paradigm [20]. At higher RF frequencies the
maximum temperature reached was slightly lower with
Tmax = 44.5 °C for 500 MHz and Tmax = 45.3 °C at 1 GHz.
The difference versus the 300 MHz setup can be attrib-
uted to pronounced power losses in tissue at these fre-
quencies leading to damping of the electromagnetic
waves. While the maximum temperatures in the center of
the brain are well above 44 °C for all configurations, sur-
face regions showed temperature elevations below 43 °C
(41 °C for 300 MHz, 39.3 °C for 500 MHz and 42.9 °C for
1 GHz) demonstrating a good selectivity of the approach.
Time dependent changes in thermoregulation have not
been modeled and might influence absolute achievable
temperatures.
Table 2 RF heating performance of 8-channel applicator designs at 300 MHz and 500 MHz
Frequency [MHz] Dimensions [mm3] Central SAR [W/kg] iso-SAR 90 % [mm3] iso-SAR 75 % [mm3] iso-SAR 50 % [mm3] iso-SAR 25 % [mm3]
300 150 × 70 × 40 216 18 × 18 × 41 29 × 29 × 70 45 × 45 × 111 65 × 65 × 157
500 150 × 70 × 40 176 10 × 10 × 40 17 × 17 × 73 27 × 27 × 138 35 × 35 × 182
500 70 × 40 × 20 116 10 × 10 × 28 17 × 17 × 48 26 × 26 × 83 25 × 25 × 155
Maximum absolute central point SAR for a total input power of 400 W and hotspot size described by iso-SAR 90 %, iso-SAR 75 %, iso-SAR 50 % and iso-SAR 25 %
along the x, y and z axis for transmit frequencies of 300 MHz and 500 MHz and for antenna building block with different dimensions
Fig. 5 Comparison of the simulated temperature distribution (left) of a single bow tie antenna driven at 500 MHz in an axial slice of a cylindrical
phantom versus MRTh measurements (middle). For simulations and experiments an RF heating paradigm of 70 W input power and a duration of
12 minutes was employed. Relative temperature distribution (ΔT) (right) along a central line (marked in green in the inlay showing the setup).
A good agreement was found between temperature simulations (red line) and MRTh (blue line)
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At higher RF frequencies smaller temperature hotspot di-
mensions were reached, indicating a more localized RF
heating performance. At 300 MHz iso-temperature 90 % of
(6 × 9) mm2, iso-temperature 75 % of (10 × 16) mm2, iso-
temperature 50 % of (18 × 50) mm2 and iso-temperature
25 % of (56 × 79) mm2 hotspot size was observed for the
axial plane (Fig. 6). For 500 MHz the hotspot dimensions
were reduced to iso-temperature 90 % of (5 × 10) mm2,
iso-temperature 75 % of (9 × 22) mm2, iso-temperature
50 % of (14 × 44) mm2 and iso-temperature 25 % of
(29 × 64) mm2 while at 1 GHz the hotspot size was only
iso-temperature 90 % of (2 × 8) mm2, iso-temperature 75 %
of (5 × 14) mm2, iso-temperature 50 % of (11 × 22)mm2
and iso-temperature 25 % of (20 × 34) mm2 (Fig. 6).
All three antenna configurations can potentially be
used for thermal MR using 7.0 T, 11.7 T or 23.5 T pro-
ton MR frequency for targeted RF heating, MRI and
MRTh. The necessary average power of 400 W as being
used in the simulation setup can be reached using the
standard RFPA of the MR system as previously demon-
strated in 300 MHz RF heating experiments [20]. A hy-
brid approach that makes good use of external RFPAs
driven at a higher RF frequency (f ≥ 300 MHz) for RF
heating together with a MR system operating at B0 =
1.5 T (64 MHz) or B0 = 3.0 T (128 MHz) for MRI and
MRTh is also feasible.
Conclusion
This study outlines the physical and technical underpin-
nings of a non-invasive RF hyperthermia device utilizing
the MR spin excitation frequency for controlled RF heat-
ing (thermal MR). EMF simulations and experiments
demonstrate the feasibility of an 8-channel applicator for
MR imaging, MR thermometry and controlled targeted
RF heating at 7.0 T. Our experiments demonstrated that
the pulsed multi-channel transmit system of a 7.0 T MR
Fig. 6 Comparison of the SAR and thermal distributions from electromagnetic and thermal simulations of three applicator configurations positioned
around the head of human voxel model “Ella” [27] with frequency dependent electromagnetic and thermal properties adjusted based on [31]. The
configurations include an 8-channel applicator at 300 MHz (left), an 8-channel applicator at 500 MHz (middle) and a 20-channel applicator at 1 GHz
(right). All three applicators were driven with a total input power of Pin= 400 W, an in-phase (no phase shift between channels) phase setting, an RF
heating duration of 3 min and a waterbolus temperature of TB = 20 °C. Maximum SAR1g in the center of the brain was 311 W/kg for
300 MHz, 240 W/kg for 500 MHz and 307 W/kg for 1 GHz. The maximum temperatures reached in the center of the brain were found to
be Tmax = 46.8 °C at 300 MHz, Tmax = 44.5 °C at 500 MHz and Tmax = 45.3 °C at 1GHz while surface regions exhibited temperatures below
43 °C (41 °C for 300 MHz, 39.3 °C for 500 MHz and 42.9 °C for 1 GHz)
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scanner supports targeted RF heating and provides
enough power (Pavg > 400 W) to induce a temperature
increase of ~10 °C in 3 min in the center of a head sized
phantom. Our EMF simulations and experimental verifi-
cations [20, 29] demonstrate that this system is able to
provide >15 % higher power absorption values in the
target region for the same input power as compared to
current non MR guided clinical RF hyperthermia sys-
tems in the head and neck region, which are able to rise
tumor temperatures up to 43 °C with average input
power levels of ~300 W [33, 34]. Modification of the RF
phases applied allowed for hotspot steering to a deliber-
ately selected location.
Our physics considerations, EMF simulations and pre-
liminary experimental results show that higher RF fre-
quencies allow for a more localized targeted RF heating
approach, confirming previous studies [17, 19, 20]. Here
the temperature hotspot dimensions could be further re-
duced at 500 MHz and 1 GHz versus the 300 MHz con-
figuration. Three applicator designs were presented,
which can potentially be utilized for thermal MR at
300 MHz, 500 MHz and 1 GHz. All configurations are
MR compatible and can be also integrated in a hybrid
approach equipped with an external RFPA used for RF
heating while MRI is being conducted at lower fields
(B0 = 1.5 T, 3.0 T). In particular, our studies demon-
strated the feasibility of using an external RFPA for
transmission at 500 MHz in conjunction with MRI and
MRTh performed at 300 MHz (B0 = 7.0 T).
In comparison to a hybrid approach, thermal MR has
the benefit of making additional RF hardware (RFPA, RF
electronics, filters, antennas) or software to drive these
components obsolete while adding another therapeutic
dimension to a diagnostic MRI device. The use of many
element local transmit/receive antennas at ultrahigh
fields offers potential signal-to-noise ratio enhancements
[35–38]. These enhancements can be translated into
spatiotemporal resolution improvements [39, 40] which
are beneficial for MR temperature mapping during RF
heating interventions. While being important to dynam-
ically control the desired temperature distribution by
adjusting the RF pulses played out at the antennas, reli-
able temperature information is crucial for a thermal
dose characterization in locations of intracranial lesion
as well as in remote healthy tissue. Although E-field or
SAR distributions cannot be measured directly with MR,
local SAR can be estimated using MR prior to an RF
heating procedure [41]. This allows for a control and
adjustment of the treatment planning parameters of
the applicator prior to the treatment. During an RF
hyperthermia treatment, MRTh can function as a tool to
retrospectively estimate SAR and correct the temperature
distribution via amplitude and phase modulation of the
RF pulses [42, 43]. Here the selectivity of the method to
provide an accurate thermal dose to a target region is yet
to be determined in-vivo. Dynamically played out RF
pulses can be optimized based upon the geometry and
shape of intracranial lesions using adapted algorithms pro-
posed to manage local SAR hotspots in parallel transmit
MR applications [44–46]. The lessons learned from RF in-
duced heating of conductive implants at 7.0 T [29, 47] can
be also put to good use to advance targeted RF heating at
300 MHz.
Our findings suggest that at 1 GHz sufficient energy
can be deposited in the center of the human brain. This
result can be exploited for targeted RF heating, but also
renders human in-vivo MRI at 23.5 T or human in-vivo
electron paramagnetic resonance (EPR) at 1 GHz and
above feasible from an electrodynamic standpoint. While
a single transmission element faces an increased power
absorption in surface regions at higher RF frequencies,
the reduction of the transmitted wavelength enables a
higher density placement of the antennas without deteri-
orating element decoupling. Exploiting this physical ad-
vantage, our simulations showed that the number of
dipole antennas can be extended to 20 with decoupling
values < −13 dB. At the same time a substrate, which
might introduce losses becomes redundant at such high
frequencies. The presented 20-channel electric dipole
array at 1 GHz (23.5 T) generates absolute B1
+ values of
~11μT/√kW in the center of the human brain while
local SAR (1 g average) values are reduced at 1 GHz by
a factor of ~2 as compared to 300 Mhz since the RF
power is spread more evenly around the surface of the
head [48]. These results provide encouragement for
whole-body MR systems with B0 ≥ 7.0 T which is in
alignment with potential future developments of UHF
MRI. A recent report of the National Research Council
on high magnetic field science and its application for-
warded a call for a 20.0 T wide bore MR system [49].
This development is inspired by the progress at 7.0 T,by
the early experience with small animal MR at 21.1 T
and the advances in ultrahigh field magnet technology
[50, 51]. The requirements of thermal MR are likely to
pave the way for further advances in MR technology and
MR systems design. With appropriate multi transmit
systems that offer more than 8 transmission channels, an
optimistically-inclined scientist might envisage the imple-
mentation of high density transceiver arrays to break
ground for a many element, two-dimensional applicator
allowing improvements in imaging performance [36] and
hotspot focusing along z-dimension [24–26].
To summarize, the strong rationale for the use of non-
invasive hyperthermia as part of a multimodal treatment
for patients with glioblastoma asks for innovations [6, 9].
Non-invasive RF hyperthermia approaches, that combine
ultrahigh-field MRI together with controlled and local-
ized RF heating, potentially offer another dimension to
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treatment efficiency and control [20]. Such system,
employed for local RF hyperthermia as an alternative
additive treatment for glioblastoma multiforme might be
able to improve local control [5] by “fighting fire with
fire” [9]. Interventions are not limited to an adjuvant to
radiotherapy alone, temperature driven targeted drug
and contrast agent delivery in conjunction with diagnostic
MR imaging and spectroscopy might improve chemother-
apeutic approaches with increased drug concentrations at
tumor site and reduced drug side effects [52–56]. Applica-
tions may not be limited to the brain but could be ex-
tended to other body regions and disease models and
might help to understand temperature dependent bio-
and physiological effects in-vivo. A limitation of thermal
MR at UHF (B0 ≥ 7.0 T) are the current costs of the MR
system, which might limit RF hyperthermia of the brain to
established high-volume treatment centers.
To conclude, the opportunities and capabilities of
thermal magnetic resonance for RF hyperthermia inter-
ventions are intriguing and in a creative state of flux.
Bringing these interventions and therapies into the clinic
remains a challenge. A story worth following since the
implications feed into a broad spectrum of MR physics,
biomedical engineering, oncology, surgery, radiology and
other related fields of basic research and clinical science.
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